Colorado Springs-based
Spectranetics said Tuesday that it is acquiring
AngioScore, a developer of specialty balloons for the cardiovascular market, in a deal worth $230M plus additional earnout. AngioScore's venture backers include California Technology Ventures, Innomed Ventures, Linkagene LP, Pelion Ventures, Psilos Group Management, QuestMark Partners, Saints Capital and Telegraph Hill Partners. The acquisition is also an exit for Salt Lake City-based Pelion Ventures.
posted on Wednesday, May 28, 2014
Related companies:
Spectranetics
Related stories:
> Spectranetics Looks To Venture Capitalists For Board Seat
> Spectranetics Appoints Exec
> Central Logic Shifts Chair To Holmes
> Pluralsight Buys Tekpub
> sPower Buys Solar Project In Idaho
Techrockies.com Home